Integral Diagnostics Limited
IDX.AX
#6954
Rank
$0.57 B
Marketcap
$1.55
Share price
-3.02%
Change (1 day)
24.05%
Change (1 year)

P/E ratio for Integral Diagnostics Limited (IDX.AX)

P/E ratio at the end of 2025: 163

According to Integral Diagnostics Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 147.553. At the end of 2025 the company had a P/E ratio of 163.

P/E ratio history for Integral Diagnostics Limited from 2016 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2025163-1750.08%
2024-9.89-134.22%
202328.9-26.83%
202239.545.97%
202127.0-2.02%
202027.644.99%
201919.0-14.58%
201822.3104.7%
201710.9-12.02%
201612.4

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.